Physician profile
Paul H Chen
NPI 1760486419
$20,846.89
in general payments reported to CMS, 2019-2025
39 companies · $2,547 in 2025
The $2,547 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,636 · 2020: $1,577 · 2021: $2,185 · 2022: $1,995 · 2023: $2,676 · 2024: $5,231 · 2025: $2,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,971 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Consulting Fee: $1,525 · Entertainment: $228 · Education: $17.84 · Travel and Lodging: $11.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,971.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Consulting Fee | $1,525.00 |
| Entertainment | $228.37 |
| Education | $17.84 |
| Travel and Lodging | $11.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,781.44 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,810.02 | 2019-2021 | |
| Allergan, INC. | $1,462.68 | 2019-2022 | |
| Ocular Therapeutix, INC. | $1,234.12 | 2019-2025 | Dextenza |
| Johnson & Johnson Surgical Vision, INC. | $913.94 | 2023-2025 | Tecnis Iol, Tecnis Simplicity |
| Abbvie INC. | $866.99 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Cipla USA INC. | $775.00 | 2025 | |
| Rxsight INC | $570.17 | 2021-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Coopervision INC. | $538.28 | 2022-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $480.09 | 2022-2024 | Miebo, Envista Mx60 Iol, Stellaris |
| Dr.Reddy'S Laboratories,INC. | $375.00 | 2021 | |
| Amgen INC. | $355.76 | 2024 | Tepezza |
| Sight Sciences, INC. | $351.63 | 2019-2024 | Omni Surgical System |
| Beaver-Visitec International, INC. | $334.27 | 2022-2023 | |
| Horizon Therapeutics Plc | $293.69 | 2022-2023 | Tepezza |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.